We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

YM BioSciences Announces FDA Clearance for Phase II Nimotuzumab Trials into USA

News   Jan 27, 2010

 
YM BioSciences Announces FDA Clearance for Phase II Nimotuzumab Trials into USA
 
 
 

RELATED ARTICLES

Tdap Vaccination for Pregnant Women Does Not Increase Risk of Autism, Finds Study

News

A Kaiser Permanente study of more than 80,000 children born over a 4-year period showed that the prenatal Tdap vaccination (tetanus, diphtheria, acellular pertussis) was not associated with increased risk of autism spectrum disorder in children.

READ MORE

Rotavirus Vaccine Cuts Infant Diarrhoea Deaths by a Third in Malawi

News

A major new study has shown that rotavirus vaccination reduced infant diarrhoea deaths by 34% in rural Malawi, a region with high levels of child deaths.

READ MORE

New Prostate Cancer Blood Test Detects Early Treatment Failure

News

This new liquid biopsy helps to track and respond to prostate cancer evolution, and identify emerging drug resistance.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE